Jason C. Jones - Mar 22, 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
VP of Product Development
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Stock symbol
EKSO
Transactions as of
Mar 22, 2022
Transactions value $
-$9,206
Form type
4
Date filed
3/28/2022, 04:44 PM
Previous filing
Feb 22, 2022
Next filing
Apr 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale -$9.21K -3.27K -3.85% $2.82* 81.6K Mar 22, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021.
F2 The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.